KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Net Cash Flow (2016 - 2026)

Medtronic (MDT) has disclosed Net Cash Flow for 13 consecutive years, with -$159.0 million as the latest value for Q1 2026.

  • Quarterly Net Cash Flow fell 562.5% to -$159.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$428.0 million through Jan 2026, down 88.55% year-over-year, with the annual reading at $746.0 million for FY2025, 2672.41% up from the prior year.
  • Net Cash Flow hit -$159.0 million in Q1 2026 for Medtronic, down from $48.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 to a low of -$2.9 billion in Q2 2023.
  • Historically, Net Cash Flow has averaged -$107.5 million across 5 years, with a median of -$4.0 million in 2024.
  • Biggest five-year swings in Net Cash Flow: surged 3036.84% in 2022 and later crashed 25200.0% in 2025.
  • Year by year, Net Cash Flow stood at $2.8 billion in 2022, then plummeted by 94.73% to $147.0 million in 2023, then plummeted by 46.26% to $79.0 million in 2024, then crashed by 39.24% to $48.0 million in 2025, then plummeted by 431.25% to -$159.0 million in 2026.
  • Business Quant data shows Net Cash Flow for MDT at -$159.0 million in Q1 2026, $48.0 million in Q4 2025, and -$1.0 billion in Q3 2025.